HBM Healthcare Investments Backs Chemomab–Scipher Merger with 12.5% Stake
HBM Healthcare Investments (Cayman) Ltd. disclosed a 12.5% stake in Chemomab Therapeutics Ltd. through American Depositary Shares and pre-funded warrants. On Jul. 16, 2026, the fund filed a Schedule 13D after steps that allow it to acquire all warrant shares within 60 days. The move supports a plan…